You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
AstraZeneca
Baxter
Mallinckrodt
McKinsey

Last Updated: August 5, 2020

DrugPatentWatch Database Preview

PSEUDOEPHEDRINE HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Pseudoephedrine Hydrochloride, and what generic alternatives are available?

Pseudoephedrine Hydrochloride is a drug marketed by Aurobindo Pharma Ltd, L Perrigo Co, Sun Pharm Inds Ltd, Cent Pharms, Graham Dm, Kv Pharm, and Sandoz. and is included in eight NDAs.

The generic ingredient in PSEUDOEPHEDRINE HYDROCHLORIDE is pseudoephedrine hydrochloride; triprolidine hydrochloride. There are forty-nine drug master file entries for this compound. Additional details are available on the pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.

Drug patent expirations by year for PSEUDOEPHEDRINE HYDROCHLORIDE
Drug Sales Revenue Trends for PSEUDOEPHEDRINE HYDROCHLORIDE

See drug sales revenues for PSEUDOEPHEDRINE HYDROCHLORIDE

Recent Clinical Trials for PSEUDOEPHEDRINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Maryland, BaltimoreN/A
CelgenePhase 1
BayerPhase 1

See all PSEUDOEPHEDRINE HYDROCHLORIDE clinical trials

US Patents and Regulatory Information for PSEUDOEPHEDRINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd PSEUDOEPHEDRINE HYDROCHLORIDE pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209008-001 Jun 9, 2017 OTC No No   Start Trial   Start Trial   Start Trial
Kv Pharm PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; pseudoephedrine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 071455-001 Mar 1, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Cent Pharms PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; pseudoephedrine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019428-001 Aug 2, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088193-001 May 17, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
L Perrigo Co PSEUDOEPHEDRINE HYDROCHLORIDE pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 075153-001 Feb 26, 1999 OTC No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Ltd PSEUDOEPHEDRINE HYDROCHLORIDE pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 077442-001 Sep 28, 2005 OTC No No   Start Trial   Start Trial   Start Trial
Graham Dm PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; pseudoephedrine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018843-001 Mar 18, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Medtronic
Merck
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.